NewsBenzingaCORRECCIÓN: Biogen reduce la previsión de BPA ajustado para el ejercicio 2026 de 15,85-16,85 dólares a 15,95-16,75 dólares frente a 12,36 dólares estimados CORRECCIÓN: Biogen reduce la previsión de BPA ajustado para el ejercicio 2026 de 15,85-16,85 dólares a 15,95-16,75 dólares frente a 12,36 dólares estimados Benzinga 2026.10.28 10:06 (GMT+0) Open on Benzinga Other news Motorola Solutions Hikes Quarterly Dividend From $1.21 To $1.34 Per Share These 9 Congress Members Could Have Increased Interest in Nvidia’s Q3 Earnings as 2026 Shareholders $100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today Needham Maintains Buy on FuboTV, Lowers Price Target to $10 BTIG Reiterates Buy on Amer Sports, Maintains $42 Price Target Ahead of Palo Alto Networks Earnings, Here's What Barchart Data Says Comes Next for PANW Stock